News
ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019
PORTLAND, Maine, Nov. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019
Conference Call Scheduled for Monday, November 11, 2019 at 4:30 PM ETPORTLAND, Maine, Nov. 05, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity
PORTLAND, Maine, Sept. 17, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™
PORTLAND, Maine, Sept. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that...
ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
PORTLAND, Maine, Aug. 12, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
Conference Call Scheduled for Tuesday, August 13, 2019 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
PORTLAND, Maine, May 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ETPORTLAND, Maine, May 07, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
PORTLAND, Maine, March 29, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...